O'Brien Greene & Co’s Anterix ATEX Stock Holding History

O'Brien Greene & Co’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-39,600	Closed	-$1.42M	–	127
2022 Q3	$1.42M	Buy	39,600 +20,400	+106%	+$847K	0.19%	81
2022 Q2	$789K	Hold	19,200	–	–	0.3%	54
2022 Q1	$1.11M	Buy	19,200 +1,000	+5%	+$54.7K	0.37%	52
2021 Q4	$1.07M	Hold	18,200	–	–	0.35%	54
2021 Q3	$1.1M	Hold	18,200	–	–	0.4%	54
2021 Q2	$1.09M	Hold	18,200	–	–	0.39%	56
2021 Q1	$858K	Buy	+18,200	New	+$749K	0.34%	59

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

JCP

Jennifer C. Price $75.5M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

O'Brien Greene & Co's ATEX Position: Q4 2022 in Review

O'Brien Greene & Co sold out of Anterix (ATEX) in Q4 2022, closing a stake of 39,600 shares — an estimated $1.42M sold.

O'Brien Greene & Co first reported a position in ATEX in Q1 2021 and held it in 7 quarters. The position peaked at $1.42M in Q3 2022. 91 funds tracked by Wall St. Rank hold ATEX as of Q4 2022.

O'Brien Greene & Co reported no remaining Anterix position as of Q4 2022 after selling out during the quarter.
O'Brien Greene & Co sold 39,600 Anterix shares in Q4 2022, an estimated $1.42M.
O'Brien Greene & Co first reported a position in Anterix in Q1 2021 and held it in 7 quarters.
O'Brien Greene & Co's Anterix position peaked at $1.42M in Q3 2022.
91 funds tracked by Wall St. Rank held Anterix as of Q4 2022.

Based on O'Brien Greene & Co's 13F filing for Q4 2022, filed 2 Feb 2023.